Abstract:Background: Germinal matrix hemorrhage (GMH) is defined by the rupture of immature blood vessels in the germinal matrix, where subsequent hemorrhage enters the subependymal zone and the cerebral lateral ventricles. The consequent blood clot has been identified as the causative factor of secondary brain injury, which triggers a series of complex parallel and sequential harmful mechanisms, including neuroinflammation. The orphan G-protein-coupled receptor 40 (GPR40), a free fatty acid (FFA) receptor 1, has been shown to exert anti-inflammatory effects when activated and improved outcomes in animal models of stroke. We aimed to investigate the anti-inflammatory effects of GPR40 and its underlying mechanisms after GMH. Methods: GMH model was induced in 7-day-old rat pups by an intraparenchymal injection of bacterial collagenase. GPR40 agonist, GW9508, was administered intranasally 1 h, 25 h, and 49 h after GMH induction. CRISPR targeting GPR40, PAK4, and KDM6B were administered through intracerebroventricular injection 48 h before GMH induction. Neurologic scores, microglia polarization, and brain morphology were evaluated by negative geotaxis, right reflex, rotarod test, foot fault test, Morris water maze, immunofluorescence staining, Western blots, and nissl staining respectfully. Results: The results demonstrated that GW9508 improved neurological and morphological outcomes after GMH in the short (24 h, 48 h, 72h) and long-term (days 21-27). However, the neuroprotective effects of treatment were abolished by GW1100, a selective GPR40 antagonist. GW9508 treatment increased populations of M2 microglia and decreased M1 microglia in periventricular areas 24 h after GMH induction. GW9508 upregulated the phosphorylation of PAK4, CREB, and protein level of KDM6B, CD206, IL-10, which was also met with the downregulation of inflammatory markers IL-1β and TNF-α. The mechanism study demonstrated that the knockdown of GPR40, PAK4, and KDM6B reversed the neuroprotective effects brought on by GW9508. This evidence suggests that GPR40/PAK4/CREB/KDM6B signaling pathway in microglia plays a role in the attenuation of neuroinflammation after GMH. Conclusions: In conclusion, the present study demonstrates that the activation of GPR40 attenuated GMH-induced neuroinflammation through the activation of the PAK4/CREB/KDM6B signaling pathway, and M2 microglia may be a major mediator of this effect. Thus, GPR40 may serve as a potential target in the reduction of the inflammatory response following GMH, thereby improving neurological outcomes in the short- and long-term.

G-protein-coupled estrogen receptor activation upregulates interleukin-1 receptor antagonist in the hippocampus after global cerebral ischemia: implications for neuronal self-defense

Anti-Inflammatory Actions of G-Protein-Coupled Estrogen Receptor 1 (GPER) and Brain-Derived Estrogen Following Cerebral Ischemia in Ovariectomized Rats

Activation of G Protein-Coupled Estrogen Receptor 1 (GPER-1) Ameliorates Blood-Brain Barrier Permeability after Global Cerebral Ischemia in Ovariectomized Rats.

Activation of GPER-1 Attenuates Traumatic Brain Injury-Induced Neurological Impairments in Mice

GPER agonist G1 suppresses neuronal apoptosis mediated by endoplasmic reticulum stress after cerebral ischemia/reperfusion injury

Modulation of GPER1 Alleviates Early Brain Injury Via Inhibition of A1 Reactive Astrocytes Activation after Intracerebral Hemorrhage in Mice

EFFECT OF ESTROGEN MEMBRANE RECEPTOR GPR30 ON APOPTOSIS OF HIPPOCAMPAL NEURONS AFTER GLOBAL CEREBAL ISCHEMIA IN POSTMENOPAUSAL RATS

Sex-dependent effects of GPER activation on neuroinflammation in a rat model of traumatic brain injury

GPER1 Mediates Estrogen-Induced Neuroprotection Against Oxygen-Glucose Deprivation in the Primary Hippocampal Neurons.

Selective Activation of G Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces ER Stress and Pyroptosis via AMPK Signaling Pathway in Experimental Subarachnoid Hemorrhage

GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment

Coupling of GPR30 mediated neurogenesis and protection with astroglial Aromatase-STAT3 signaling in rat hippocampus after global cerebral ischemia

GPER expressed on microglia mediates the anti‐inflammatory effect of estradiol in ischemic stroke

Activation of G-protein Coupled Estrogen Receptor 1 Improves Early-Onset Cognitive Impairment Via PI3K/Akt Pathway in Rats with Traumatic Brain Injury.

The Novel Estrogenic Receptor GPR30 Alleviates Ischemic Injury by Inhibiting TLR4-mediated Microglial Inflammation

G-Protein-Coupled Receptor 30 Mediates Rapid Neuroprotective Effects of Estrogen Via Depression of NR2B-Containing NMDA Receptors

Gper Expressed on Microglia Mediates the Anti-Inflammatory Effect Ofestradiol in Ischemic Stroke

Neuroprotective Effects of Prostaglandin A(1) in Rat Models of Permanent Focal Cerebral Ischemia Are Associated with Nuclear Factor-Kappa B Inhibition and Peroxisome Proliferator-Activated Receptor-Gamma Up-Regulation

Ginsenoside Rg1 Exerts Anti-inflammatory Effects via G Protein-Coupled Estrogen Receptor in Lipopolysaccharide-Induced Microglia Activation

Activation of GPR40 attenuates neuroinflammation and improves neurological function via PAK4/CREB/KDM6B pathway in an experimental GMH rat model

Activation of GPR30 with G1 attenuates neuronal apoptosis via src/EGFR/stat3 signaling pathway after subarachnoid hemorrhage in male rats.